By Stephen Nakrosis
AMN Healthcare Services said Mark Foletta was named its new chairman of the board.
He succeeds Douglas Wheat, who had served on the board since 1999.
Foletta, who joined the board in 2012, served as vice president and chief financial officer of Tocagen from February 2017 until March 2020. Prior to that, he was interim CFO of Biocept, and SVP, finance and CFO of Amylin Pharmaceuticals.
Foletta currently is on the boards of DexCom and Entanta Pharmaceuticals. He previously served on other company boards, including Regulus Therapeutics and Ambit Biosciences, AMN said Friday.
AMN provides healthcare staffing services and workforce solutions.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
February 07, 2025 16:38 ET (21:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.